It wants to get ahead of competitors such as BMS, Merck, Pfizer ... The interaction with GSK goes deeper, with Novartis and GSK announcing a merger of their OTC divisions to create a new joint ...
Pfizer and GSK plan to divest the business completely ... and the deal was instantly controversial in both Europe and the US. The merger would have created the biggest pharmaceutical company ...
Parke-Davis (India) in the near future is unlikely to get five major products which Glaxo Wellcome worldwide ... The operational merger between Pfizer and Parke-Davis has been completed and ...
Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...
Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...
GSK is the fifth company to leave BIO in roughly a year, a group that includes Pfizer and UCB. The departures coincided with ...
GSK is the fifth company to leave BIO in roughly a year, a group that includes Pfizer (PFE). The departures coincided with a drop in lobbying spending from the group and other challenges, STAT says.
Pfizer (PFE) stock in focus as company is eyeing to sell its hospital drugs unit, Pfizer Hospital, potentially worth billions ...
Hosted on MSN23h
GSK lowered to hold by Jefferies, valuation disconnect citedJefferies lowered GSK (NYSE:GSK) to hold, citing a valuation disconnect between fundamentals and price. Jefferies said it ...
Pfizer (PFE) is exploring the sale of its hospital drugs unit, now called Pfizer Hospital, which was formed after Pfizer bought Hospira for ...
The billionaire founders of pharmacy chain Chemist Warehouse are a step closer to creating a $28.9 billion sharemarket giant after the competition regulator said their planned merger with ASX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback